Showing 3 posts of 3 posts found.


University of Illinois at Chicago’s new breast cancer drug is safe and can halt disease progression, according to a Phase 1 trial

August 28, 2020
Medical Communications Cancer, Cancers, breast cancer

A new breast cancer drug, called TTC-352, can halt the spread of the disease and is safe according to a …


Researchers modify T-cells to identify and target multiple sites on leukaemia cells

April 1, 2020
Research and Development Cancer, Cancers, children cancer, leukaemia

Scientists from the Children’s Hospital of Los Angeles have engineered T-cells to identify and target multiple sites on acute lymphoblastic …


Bristol-Myers Squibb demonstrates potential for long-term survival in kidney cancer patients treated with Opdivo plus Yervoy

February 20, 2020
Business Services Cancer, Cancers, Yervoy, opdivo, renacl cell carcinoma, renal cancer

Bristol-Myers Squibb has announced updated results from trialing Opdivo (nivolumab) plus Yervoy (ipilimumab) versus sunitinib in patients with previously untreated …

Latest content